TrialThe Journal of clinical investigation2019

IFN-γ drives inflammatory bowel disease pathogenesis through VE-cadherin-directed vascular barrier disruption.

Victoria Langer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.